• RepSox (ALK5 Inhibitor): Optimizing iPSC Platelet Differenti

  2026-04-29

  RepSox, a potent and selective ALK5 inhibitor, is redefining induced pluripotent stem cell (iPSC) workflows by unlocking cost-effective, high-yield platelet production. This article translates the latest experimental innovations and troubleshooting insights into actionable guidance for cell therapy and advanced TGF-β pathway research.

• Amikacin Sulfate: Intracellular Pharmacology and Targeted De

  2026-04-28

  Explore the intracellular pharmacology of Amikacin Sulfate and its role in targeted drug delivery for non-tuberculous mycobacterial infections. This in-depth guide uncovers advanced uptake mechanisms and translational assay strategies for optimizing antibiotic research.

• Biotin-tyramide: Precision Amplification for Proximity Prote

  2026-04-28

  Explore how biotin-tyramide empowers enzyme-mediated signal amplification in proximity labeling and proteomics, with unique insights into practical assay optimization, protocol parameters, and the latest APEX2-biotin phenol breakthroughs. This article delivers actionable, evidence-based guidance for advanced molecular detection.

• BML-277: Selective Chk2 Inhibitor for DNA Damage Response As

  2026-04-27

  BML-277 stands out as a potent and highly selective Chk2 inhibitor, optimized for dissecting DNA damage response pathways and radioprotecting human T-cells. This guide details experimental workflows, real-world troubleshooting, and insights from recent nuclear cGAS–Chk2 studies, making BML-277 a go-to tool for advanced genome integrity and cancer research.

• GSK343: EZH2 Inhibitor Workflow Innovations for Cancer Resea

  2026-04-27

  Leverage GSK343's precision as a selective EZH2 inhibitor to dissect PRC2-mediated epigenetic silencing and drive breakthroughs in breast and prostate cancer research. This guide distills cutting-edge protocols, assay optimization, and troubleshooting tactics for maximizing reproducibility and biological insight with APExBIO's GSK343.

• Lipid Scrambling, Ferroptosis, and Tumor Immunity: TMEM16F’s

  2026-04-26

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a crucial suppressor of ferroptosis at the plasma membrane, linking its inhibition to enhanced tumor cell death and robust antitumor immunity. These findings refine our understanding of ferroptosis execution and suggest new avenues for cancer immunotherapy.

• CDK9 Inhibitor (A3294): Technical Guidance and Workflow Use

  2026-04-25

  The CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for research applications targeting cyclin dependent kinase 9. It is optimized for studies on transcription elongation inhibition and HIV-1 propagation inhibition, where high selectivity and minimal cytotoxicity are required. This reagent is not suited for pan-CDK inhibition or protocols needing long-term solution storage.

• Tetracycline in Research: Protocols, Applications & Troubles

  2026-04-24

  Tetracycline stands out as a broad-spectrum polyketide antibiotic not only for its classical role in selection and inhibition of bacterial protein synthesis but also for its expanding use in advanced ribosomal and ER stress research. This article delivers a practical, evidence-driven guide to maximizing tetracycline’s value in experimental workflows, integrating troubleshooting insights and highlighting key innovations from recent disease modeling studies.

• HyperScribe™ Poly (A) Tailing Kit: Optimizing mRNA Stability

  2026-04-24

  The HyperScribe™ Poly (A) Tailing Kit empowers researchers to produce highly stable, transfection-ready mRNA by enzymatically polyadenylating in vitro transcripts with E. coli Poly (A) Polymerase. Its robust, reproducible protocol accelerates advanced gene expression workflows and overcomes common RNA processing bottlenecks.

• Praeruptorin A: Translational Leverage in Cancer and Inflamm

  2026-04-23

  This expert thought-leadership article explores Praeruptorin A, an angular pyranocoumarin compound, as a multifaceted research tool for translational scientists. By dissecting its mechanistic roles in ferroptosis inhibition, anti-inflammatory signaling, and metastatic suppression—especially in hepatocellular carcinoma—this piece provides actionable guidance, protocol insights, and a visionary outlook for advancing disease-modifying research. Drawing on primary and secondary literature as well as workflow best practices, it goes beyond standard product summaries to map strategic applications for Praeruptorin A in experimental and preclinical models.

• Structural Insights into HCAR3 Agonist Binding and Selectivi

  2026-04-23

  Ye et al. (2025) provide high-resolution cryo-EM structures of the hydroxycarboxylic acid receptor HCAR3 bound to selective agonists, including (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid (Acifran). Their findings elucidate the molecular determinants of ligand recognition and selectivity, paving the way for rational design of specific hypolipidemic agents with improved safety profiles.

• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio

  2026-04-22

  The reference study identifies ATG9A and PTOV1 as new 14-3-3 binding proteins, elucidating their roles in autophagy and cancer signaling. These findings significantly expand our molecular understanding of tumorigenic mechanisms and highlight new potential targets for regulated cell therapy and conditional gene expression research.

• DAPI (hydrochloride): Optimizing DNA Visualization in Tumor

  2026-04-22

  DAPI (hydrochloride) delivers high-contrast, sequence-selective DNA staining, accelerating cell cycle analysis and tumor microenvironment profiling. This guide walks through advanced workflows, robust troubleshooting, and expert tips—empowering precise research outcomes with APExBIO's trusted staining reagent.

• APEX2 Is Essential for TERT Expression in Human Stem Cells

  2026-04-21

  This study demonstrates that the DNA repair enzyme APEX2, unlike its paralog APEX1, is required for efficient telomerase reverse transcriptase (TERT) gene expression in human embryonic stem cells and melanoma cells. The findings reveal novel mechanistic links between DNA repair, repetitive DNA elements, and the regulation of telomerase, with implications for stem cell biology, aging, and cancer.

• OTC-Mediated Ornithine Regulation Drives Realgar CNS Toxicit

  2026-04-21

  This study delineates how realgar, an arsenic-containing compound, disrupts the liver–brain axis by inhibiting hepatic ornithine transcarbamylase (OTC), leading to ornithine accumulation and subsequent repression of astrocytic glycolysis via ZBTB7A. These findings clarify the molecular cascade underlying realgar-induced CNS toxicity and highlight new directions for targeted prevention and mechanistic research.

406 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page